Manisit's research focuses on immuno-oncology, drug delivery, nonviral gene therapy, and tumor microenvironment. He has expertise in preclinical mouse models of cancer, nanoparticle formulations, and bioanalytical assays. Currently, he is using a lipid nanoparticle platform to deliver innate immune signaling activators for immunotherapy in pancreatic cancer.